semaglutide cv benefit Beyond obesity: Novo's SELECT re-defines cardiovascular risk management New Science Suggests Semaglutide Improves

Nuwayhid said

Price matters, but not as much as batch confidence and vendor reliability

Its original purpose was not weight loss, but improved blood sugar control in patients for whom standard therapy was no longer sufficient

Not a GLP-1 medication

They are released throughout the day, increasing at mealtimes, and have several functions: Stimulate the production and secretion of insulin in response to eating (glucose-dependent insulin secretion) GLP-1 enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion Slow digestion and decrease appetite Thus, DPP-4 inhibitors indirectly enhance insulin release, suppress glucagon secretion, and improve glycaemic control

As an investigational peptide, any legitimate clinical use involves a licensed provider, a prescription, and compounding through a licensed pharmacy